John P. Brancaccio, Director at Hepion Pharmaceuticals, Inc. (HEPA), bought 7,000 shares at $1.53 ($11K) on 2020-12-02, disclosed to the SEC on 2020-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CRDF | BUY | 2020-05-18 | $10K | — | Filing → |
| TROV | BUY | 2018-06-13 | $8K | — | Filing → |
| SGYP | BUY | 2017-05-30 | $23K | — | Filing → |